Edward J. Quinlan, Richard Chubet, & Peter Leonardi. (2022). A novel SARS-CoV-2 subunit vaccine engineered on an immune-activating platform technology. Taylor & Francis Group.
Chicago Style (17th ed.) CitationEdward J. Quinlan, Richard Chubet, and Peter Leonardi. A Novel SARS-CoV-2 Subunit Vaccine Engineered on an Immune-activating Platform Technology. Taylor & Francis Group, 2022.
MLA (9th ed.) CitationEdward J. Quinlan, et al. A Novel SARS-CoV-2 Subunit Vaccine Engineered on an Immune-activating Platform Technology. Taylor & Francis Group, 2022.
Warning: These citations may not always be 100% accurate.